
Amber D. Steele
Examiner (ID: 11314, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1639, 1654, 1676, 1658 |
| Total Applications | 1278 |
| Issued Applications | 622 |
| Pending Applications | 159 |
| Abandoned Applications | 534 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4880467
[patent_doc_number] => 20080153850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'Adamantyl Derivates as P2x7 Receptor Antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/574343
[patent_app_country] => US
[patent_app_date] => 2005-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44064
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153850.pdf
[firstpage_image] =>[orig_patent_app_number] => 11574343
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/574343 | Adamantyl Derivates as P2x7 Receptor Antagonists | Aug 28, 2005 | Abandoned |
Array
(
[id] => 5820080
[patent_doc_number] => 20060024393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases'
[patent_app_type] => utility
[patent_app_number] => 11/202986
[patent_app_country] => US
[patent_app_date] => 2005-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23195
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024393.pdf
[firstpage_image] =>[orig_patent_app_number] => 11202986
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/202986 | Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases | Aug 11, 2005 | Abandoned |
Array
(
[id] => 4740684
[patent_doc_number] => 20080234337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-25
[patent_title] => 'Preventive and/or Remedy for Hyperkalemia Containing Ep4 Agonist'
[patent_app_type] => utility
[patent_app_number] => 11/660048
[patent_app_country] => US
[patent_app_date] => 2005-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 23281
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20080234337.pdf
[firstpage_image] =>[orig_patent_app_number] => 11660048
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/660048 | Preventive and/or Remedy for Hyperkalemia Containing Ep4 Agonist | Aug 8, 2005 | Abandoned |
Array
(
[id] => 4570255
[patent_doc_number] => 07858610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-12-28
[patent_title] => 'Preventive and/or remedy for lower urinary tract diseases containing EP4 agonist'
[patent_app_type] => utility
[patent_app_number] => 11/660043
[patent_app_country] => US
[patent_app_date] => 2005-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 25030
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/858/07858610.pdf
[firstpage_image] =>[orig_patent_app_number] => 11660043
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/660043 | Preventive and/or remedy for lower urinary tract diseases containing EP4 agonist | Aug 8, 2005 | Issued |
Array
(
[id] => 5297253
[patent_doc_number] => 20090012179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-08
[patent_title] => 'Use of Tyrphostins to Stimulate Neurite Outgrowth'
[patent_app_type] => utility
[patent_app_number] => 11/658618
[patent_app_country] => US
[patent_app_date] => 2005-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13203
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0012/20090012179.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658618
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658618 | Use of Tyrphostins to Stimulate Neurite Outgrowth | Aug 3, 2005 | Abandoned |
Array
(
[id] => 4916371
[patent_doc_number] => 20080096972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'COMPOUND FORMULATIONS OF 2-AMINO-1, 3-PROPANEDIOL COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 11/572028
[patent_app_country] => US
[patent_app_date] => 2005-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6849
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096972.pdf
[firstpage_image] =>[orig_patent_app_number] => 11572028
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/572028 | COMPOUND FORMULATIONS OF 2-AMINO-1, 3-PROPANEDIOL COMPOUNDS | Jul 28, 2005 | Abandoned |
Array
(
[id] => 7518494
[patent_doc_number] => 07972595
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-05
[patent_title] => 'Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analog'
[patent_app_type] => utility
[patent_app_number] => 11/191901
[patent_app_country] => US
[patent_app_date] => 2005-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 10631
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/972/07972595.pdf
[firstpage_image] =>[orig_patent_app_number] => 11191901
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/191901 | Methods and compositions for protecting and treating at least one muscarinic receptor from dysfunction not resulting from oxidative stress, toxic actions of metals or infectious agents by administering a pyrophosphate analog | Jul 27, 2005 | Issued |
Array
(
[id] => 4711735
[patent_doc_number] => 20080300261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Arylacetic Acids and Related Compounds for Treatment of Alzheimer\'s Disease'
[patent_app_type] => utility
[patent_app_number] => 11/658242
[patent_app_country] => US
[patent_app_date] => 2005-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17303
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20080300261.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658242
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658242 | Arylacetic Acids and Related Compounds for Treatment of Alzheimer's Disease | Jul 18, 2005 | Abandoned |
Array
(
[id] => 5236128
[patent_doc_number] => 20070128285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Pharmaceutical composition for oral administration'
[patent_app_type] => utility
[patent_app_number] => 10/566829
[patent_app_country] => US
[patent_app_date] => 2005-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6638
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128285.pdf
[firstpage_image] =>[orig_patent_app_number] => 10566829
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/566829 | Pharmaceutical composition for oral administration | Jul 11, 2005 | Abandoned |
Array
(
[id] => 4840380
[patent_doc_number] => 20080280866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-13
[patent_title] => 'Method of Treating or Sepsis'
[patent_app_type] => utility
[patent_app_number] => 11/658116
[patent_app_country] => US
[patent_app_date] => 2005-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9619
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20080280866.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658116
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658116 | Method of Treating or Sepsis | Jul 6, 2005 | Abandoned |
Array
(
[id] => 4867496
[patent_doc_number] => 20080146555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Uses of Kinase Inhibitors and Compositions Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/629638
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 50352
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20080146555.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629638
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629638 | Uses of Kinase Inhibitors and Compositions Thereof | Jun 16, 2005 | Abandoned |
Array
(
[id] => 5813912
[patent_doc_number] => 20060084085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Methods and compositions for modulating Bax-mediated apoptosis'
[patent_app_type] => utility
[patent_app_number] => 11/154293
[patent_app_country] => US
[patent_app_date] => 2005-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 46238
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084085.pdf
[firstpage_image] =>[orig_patent_app_number] => 11154293
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/154293 | Methods and compositions for modulating Bax-mediated apoptosis | Jun 15, 2005 | Abandoned |
Array
(
[id] => 5063620
[patent_doc_number] => 20070225260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-27
[patent_title] => 'Amino-Propanol Derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/568645
[patent_app_country] => US
[patent_app_date] => 2005-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7959
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0225/20070225260.pdf
[firstpage_image] =>[orig_patent_app_number] => 11568645
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/568645 | Amino-propanol derivatives | May 24, 2005 | Issued |
Array
(
[id] => 4814042
[patent_doc_number] => 20080194673
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Environment-Friendly Pollution-Proof Agent'
[patent_app_type] => utility
[patent_app_number] => 11/629814
[patent_app_country] => US
[patent_app_date] => 2005-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 9735
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194673.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629814
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629814 | Environment-Friendly Pollution-Proof Agent | May 22, 2005 | Abandoned |
Array
(
[id] => 8543433
[patent_doc_number] => 08318724
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-11-27
[patent_title] => 'Small molecule inhibitors of MRP1 and other multidrug transporters'
[patent_app_type] => utility
[patent_app_number] => 11/579779
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 6402
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11579779
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/579779 | Small molecule inhibitors of MRP1 and other multidrug transporters | May 12, 2005 | Issued |
Array
(
[id] => 4670460
[patent_doc_number] => 20080045520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Substituted Pyrrolidine Derivative'
[patent_app_type] => utility
[patent_app_number] => 11/596318
[patent_app_country] => US
[patent_app_date] => 2005-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29343
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045520.pdf
[firstpage_image] =>[orig_patent_app_number] => 11596318
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/596318 | Substituted pyrrolidine derivative | May 12, 2005 | Issued |
Array
(
[id] => 7225833
[patent_doc_number] => 20050255161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Method for the long term stabilization of labile compounds at room temperature in pharmaceutical preparations containing water'
[patent_app_type] => utility
[patent_app_number] => 11/125545
[patent_app_country] => US
[patent_app_date] => 2005-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8319
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255161.pdf
[firstpage_image] =>[orig_patent_app_number] => 11125545
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/125545 | Method for the long term stabilization of labile compounds at room temperature in pharmaceutical preparations containing water | May 8, 2005 | Abandoned |
Array
(
[id] => 6930851
[patent_doc_number] => 20050281886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-22
[patent_title] => 'Particles for the delivery of active agents'
[patent_app_type] => utility
[patent_app_number] => 11/123958
[patent_app_country] => US
[patent_app_date] => 2005-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10765
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20050281886.pdf
[firstpage_image] =>[orig_patent_app_number] => 11123958
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/123958 | Particles for the delivery of active agents | May 5, 2005 | Abandoned |
Array
(
[id] => 102238
[patent_doc_number] => 07727961
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-01
[patent_title] => 'Antioxidant constituents'
[patent_app_type] => utility
[patent_app_number] => 11/118368
[patent_app_country] => US
[patent_app_date] => 2005-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8389
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/727/07727961.pdf
[firstpage_image] =>[orig_patent_app_number] => 11118368
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/118368 | Antioxidant constituents | May 1, 2005 | Issued |
Array
(
[id] => 4432827
[patent_doc_number] => 07897579
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-03-01
[patent_title] => 'Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases'
[patent_app_type] => utility
[patent_app_number] => 11/587961
[patent_app_country] => US
[patent_app_date] => 2005-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11081
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/897/07897579.pdf
[firstpage_image] =>[orig_patent_app_number] => 11587961
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/587961 | Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases | Apr 28, 2005 | Issued |